Recently, Rendu Biotech and India's renowned company, Green Apple Medical System, officially signed a strategic cooperation agreement in Shanghai. This collaboration marks a significant milestone in Rendu Biotech's international expansion. Leveraging their respective strengths, both parties will work together to promote the widespread adoption of RNA diagnostic technology in India and other markets. This partnership will contribute to the implementation of efficient and precise medical solutions while advancing the precision medicine industry towards greater intelligence and convenience.
Joining Forces to Expand the Global Market
In recent years, the global in vitro diagnostics market has maintained rapid growth. According to the latest market research report, the market size is expected to exceed $150 billion by 2030. As one of the fastest-growing healthcare markets worldwide, India has an increasing demand for high-precision and rapid diagnostic technologies. This collaboration aligns with this global trend, as both parties work together to advance the adoption of RNA diagnostic technology in India and Southeast Asia, providing innovative solutions for the global healthcare industry.